Raphael Pharmaceutical (RAPH) Net Income Growth (1y) (2021 - 2024)
Raphael Pharmaceutical (RAPH) Net Income Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 68.18% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -0.17% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.68% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,405.06% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -615.22% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -14.93% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 62.34% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 237.83% |
| 10 | Raphael Pharmaceutical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -394.03% |
| Sep 30, 2024 | 56.24% |
| Jun 30, 2024 | 40.57% |
| Mar 31, 2024 | -112.02% |
| Dec 31, 2023 | 112.14% |
| Sep 30, 2023 | 48.88% |
| Jun 30, 2023 | 31.54% |
| Mar 31, 2023 | -47.43% |
| Dec 31, 2022 | -92.33% |
| Sep 30, 2022 | -241.15% |
| Jun 30, 2022 | -58.96% |
| Mar 31, 2022 | 30.56% |
| Dec 31, 2021 | -152.86% |
| Sep 30, 2021 | -77.87% |